Fernando Israel MD - Davenport, Iowa 52806

Fernando Israel MD is categorized under Doctors in Davenport, IA .

Business Name: Fernando Israel MD
Contact Person: Israel Fernando
Address: 3906 Lillie Avenue # 4, Davenport, Iowa 52806
Phone Number: (563) 445-1682
Annual Revenue (USD): $100.000 to $499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Robert D Mixsell Md - Davenport, IA 52806
Goettsch G H MD - Davenport, IA 52806
Iltis Mark P MD - Davenport, IA 52806
Sandberg Samuel MD - Davenport, IA 52806
Huettman Jr Packy A DO - Davenport, IA 52806
Hartmann Paul MD - Davenport, IA 52806
Patton J J MD - Davenport, IA 52806
Taslimi Jalal MD - Davenport, IA 52806
D'Angelo Jr Anthony DO - Davenport, IA 52806
Syfert Richard L DO - Davenport, IA 52806
Andersen Kurt MD - Davenport, IA 52806
Mc Laughlin Christa MD - Davenport, IA 52806
Crome Christopher MD - Davenport, IA 52806
Mixsell Robert MD - Davenport, IA 52806
William Colantoni Jr Pc - Davenport, IA 52806
Shanks Candace F MD - Davenport, IA 52806
Roberts Stan K DO - Davenport, IA 52806
Boccuzzi Lorenzo DO - Davenport, IA 52806
Strom Steven DO - Davenport, IA 52806
Thompson Steven M DO - Davenport, IA 52806

The company Fernando Israel MD provides B2C services in the form of Doctors from its single location in Iowa. 1 to 4 employees work for Fernando Israel MD, and the business now earns $100.000 to $499.999 per annum.

Fernando Israel MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Fernando Israel MD, please call Israel Fernando with the phone number (563) 445-1682 or visit its single location at 3906 Lillie Avenue # 4 in Davenport, Iowa 52806.

The location of the single location can also be found using the coordinates 41.56114,-90.58891. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.